Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations

about

Trial designs for chemotherapy-induced peripheral neuropathy prevention: ACTTION recommendations

Item

http://www.wikidata.org/entity/Q57167257

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 27 July 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@en

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@nl

type

Item

label

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@en

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@nl

prefLabel

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@en

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@nl

P1476

Trial designs for chemotherapy ...... ntion: ACTTION recommendations

@en

P2093

A Gordon Smith

http://www.w3.org/2001/XMLSchema#string

Ann O'Mara

http://www.w3.org/2001/XMLSchema#string

Charles Loprinzi

http://www.w3.org/2001/XMLSchema#string

Daniela Dastros-Pitei

http://www.w3.org/2001/XMLSchema#string

Dennis C Turk

http://www.w3.org/2001/XMLSchema#string

Ellen M Lavoie-Smith

http://www.w3.org/2001/XMLSchema#string

Jennifer S Gewandter

http://www.w3.org/2001/XMLSchema#string

Joanna Brell

http://www.w3.org/2001/XMLSchema#string

Lynn Howie

http://www.w3.org/2001/XMLSchema#string

Lynn R Gauthier

http://www.w3.org/2001/XMLSchema#string

P2860

Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

The prevention and treatment of missing data in clinical trials

Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group.

Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy.

Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments.

Acetyl-L-carnitine (ALCAR) for the prevention of chemotherapy-induced peripheral neuropathy in patients with relapsed or refractory multiple myeloma treated with bortezomib, doxorubicin and low-dose dexamethasone: a study from the Wisconsin Oncology

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

The Mini-BESTest--a clinically reproducible tool for balance evaluations in mild to moderate Parkinson's disease?

A new device to quantify tactile sensation in neuropathy

P304

403-413

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000006083

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Cavaletti

Paul G Richardson

P577

2018-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30054438

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

6133627

http://www.w3.org/2001/XMLSchema#string